Similarly, many of the AChE inhibiting drugs used in the treatment of Alzheimer's disease, such as tacrine, physostigmine, and galantamine, display concentration-dependent, dual modulation of agonist activation of the α7-nAChR [73]–[74]. The gene discussed is CHRNA7; the disease is early-onset autosomal dominant Alzheimer disease.